ARCT

Arcturus Therapeutics Holdings (ARCT)

About Arcturus Therapeutics Holdings (ARCT)

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Details

Daily high

$11.77

Daily low

$10.21

Price at open

$10.35

52 Week High

$45.00

52 Week Low

$8.04

Market cap

285.6M

Dividend yield

0.00%

Volume

330,371

Avg. volume

462,894

P/E ratio

-3.51

Arcturus Therapeutics Holdings News